Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miroslav Peřina
Observed names:
M. Peřina,
Miroslav Perina,
Perina, Miroslav,
Peřina, Miroslav
Institution:
Palacký University Olomouc
Observed institutions:
Innsbruck Medical University,
Universität Innsbruck,
Czech Academy of Sciences,
Czech Academy of Sciences, Institute of Experimental Botany,
Palacký University Olomouc
ORCID:
0000-0001-5861-8688
Observed ORCID:
0000-0001-5861-8688
OpenAlex ID:
A5074499573
Modulation of FLT3-ITD and CDK9 in acute myeloid leukaemia cells by novel proteolysis targeting chimera (PROTAC)
2022
·
Eva Řezníčková
, Soňa Krajčovičová
, et al.
·
European Journal of Medicinal Chemistry
·
43
PDF
3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders
2022
·
Radek Jorda
, Libor Havlíček
, et al.
·
Journal of Medicinal Chemistry
·
40
3 H -Pyrazolo[4,3- f ]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo
2021
·
Neetu Dayal
, Eva Řezníčková
, et al.
·
Journal of Medicinal Chemistry
·
28
3,5,7-Substituted Pyrazolo[4,3- d ]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models
2019
·
Radek Jorda
, Libor Havlíček
, et al.
·
Journal of Medicinal Chemistry
·
27
Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancer
2021
·
Márton A. Kiss
, Miroslav Peřina
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
19
PDF
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7
2023
·
Markéta Kovalová
, Libor Havlíček
, et al.
·
Biomedicine & Pharmacotherapy
·
17
Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure
2021
·
Josef Jansa
, Radek Jorda
, et al.
·
European Journal of Medicinal Chemistry
·
16
Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents
2022
·
Anton S. Rudovich
, Miroslav Peřina
, et al.
·
International Journal of Molecular Sciences
·
10
PDF
Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors
2024
·
Mahfam Moradi
, Alireza Mousavi
, et al.
·
European Journal of Medicinal Chemistry
·
9
Targeting the CLK 2/ SRSF 9 splicing axis in prostate cancer leads to decreased ARV 7 expression
2024
·
Jasper Van Goubergen
, Miroslav Peřina
, et al.
·
Molecular Oncology
·
9
Ring-fused 3β-acetoxyandrost-5-enes as novel neuroprotective agents with cholinesterase inhibitory properties
2022
·
Gabriel Gonzalez
, Miroslav Kvasnica
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
8
PDF
Synthesis and biological activity evaluation of novel 2,6,9-trisubstituted purine conjugates as potential protein kinases inhibitors
2022
·
Kristýna Vlková
, Tomáš Gucký
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
6
Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates
2024
·
Miroslav Peřina
, Rita Börzsei
, et al.
·
European Journal of Pharmaceutical Sciences
·
5
Dihydrotestosterone-based A-ring-fused pyridines: Microwave-assisted synthesis and biological evaluation in prostate cancer cells compared to structurally related quinolines
2023
·
Márton A. Kiss
, Miroslav Peřina
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
5
PDF
A-ring-fused pyrazoles of dihydrotestosterone targeting prostate cancer cells via the downregulation of the androgen receptor
2023
·
Miroslav Peřina
, Márton A. Kiss
, et al.
·
European Journal of Medicinal Chemistry
·
5
PDF
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors
2022
·
Monika Tomanová
, Karolína Kozlanská
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Synthesis and biological activity evaluation of novel 3,5,7-trisubstituted pyrazolo[1,5-a]pyrimidines
2022
·
Kristýna Vlková
, Růžena Padrtová
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
5
3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia
2025
·
Neetu Dayal
, Eva Řezníčková
, et al.
·
European Journal of Medicinal Chemistry
·
4
Synthesis of hydrocortisone esters targeting androgen and glucocorticoid receptors in prostate cancer in vitro
2023
·
Miroslav Peřina
, Anita Kiss
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
4
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin
2025
·
Miroslav Peřina
, Márton A. Kiss
, et al.
·
Archiv der Pharmazie
·
3
PDF
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity
2026
·
Wagdy M. Eldehna
, Haytham O. Tawfik
, et al.
·
Frontiers in Pharmacology
·
2
PDF
The methioninase from the alkalithermophile Thermobrachium celere possesses suitable properties for treatment of cancer
2025
·
Nathan Ferchaud
, David Kopečný
, et al.
·
International Journal of Biological Macromolecules
·
1
CDK2-based CDK7 mimic as a tool for structural analysis: Biochemical validation and crystal structure with SY5609
2024
·
Jana Škerlová
, Veronika Krejčiříková
, et al.
·
International Journal of Biological Macromolecules
·
1
Structure-guided design of 7-azaindole FLT3 inhibitors for acute myeloid leukemia
2026
·
Lukas Gorecki
, Darina Muthna
, et al.
·
Journal of Translational Medicine
hsa-miR-574-5p decreases expression of prostate cancer therapy resistance driver ARV7
2026
·
Morales, Elisa
, Van Goubergen, Jasper
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
38
Citation count:
273
H-index:
9
I10-index:
8
Year
Topic
Type